Bollard Group LLC Exact Sciences Corp Transaction History

Bollard Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $26,102 - $55,876	-733 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $577,245 - $801,614	-7,962 Reduced 91.57%	733 $57,000
Q1 2021 May 11, 2021	BUY	$116.57 - $155.01 $928,130 - $1.23 Million	7,962 Added 1086.22%	8,695 $1.15 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $40,864 - $67,985	733 New	733 $64,000

671

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.77B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

Stay updated on Bollard Group LLC with notifications on news.